BRIEF-Alliance Pharma buys Syntometrinetm rights from Novartis

LONDON, June 6 Thu Jun 6, 2013 2:16am EDT

Related Topics

LONDON, June 6 (Reuters) - Alliance Pharma PLC : * Acquired all existing rights to SyntometrineTM from Novartis for

$11.5 million

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.